|
English
|
正體中文
|
简体中文
|
2819131
|
|
???header.visitor??? :
28511288
???header.onlineuser??? :
583
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"harbeck n and huang c s and hu"???jsp.browse.items-by-author.description???
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2018-09-10T15:38:29Z |
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): An open-label, randomised, phase 3 trial
|
Harbeck, N. and Huang, C.-S. and Hurvitz, S. and Yeh, D.-C. and Shao, Z. and Im, S.-A. and Jung, K.H. and Shen, K. and Ro, J. and Jassem, J. and Zhang, Q. and Im, Y.-H. and Wojtukiewicz, M. and Sun, Q. and Chen, S.-C. and Goeldner, R.-G. and Uttenreuther-Fischer, M. and Xu, B. and Piccart-Gebhart, M.; CHIUN-SHENG HUANG |
Showing items 1-1 of 1 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
